ANALYSIS OF PROGNOSTIC FACTORS IN STAGE-I EPITHELIAL OVARIAN-CARCINOMA - IMPORTANCE OF DEGREE OF DIFFERENTIATION AND DEOXYRIBONUCLEIC-ACID PLOIDY IN PREDICTING RELAPSE

被引:108
作者
VERGOTE, IB
KAERN, J
ABELER, VM
PETTERSEN, EO
DEVOS, LN
TROPE, CG
机构
[1] NORWEGIAN RADIUM HOSP,DEPT PATHOL,N-0310 MONTEBELLO,NORWAY
[2] NORWEGIAN RADIUM HOSP,DEPT TISSUE CULTURE,N-0310 MONTEBELLO,NORWAY
关键词
OVARIAN NEOPLASMS; PROGNOSIS; DEOXYRIBONUCLEIC ACID; FLOW CYTOMETRY;
D O I
10.1016/0002-9378(93)90129-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVES: Our purpose was to identity prognostic factors in stage I epithelial invasive ovarian carcinoma. STUDY DESIGN: The traditional clinical and pathologic prognostic variables and deoxyribonucleic acid ploidy were analyzed in a group of 290 patients. RESULTS: A multivariate analysis identified degree of differentiation as the most powerful prognostic indicator of disease-free survival, followed by deoxyribonucleic acid ploidy and, finally, international Federation of Gynecology and Obstetrics (1986) stage. Tumors with clear cell carcinoma elements were not graded, and in this subgroup International Federation of Gynecology and Obstetrics (1986) stage was the most important prognostic characteristic. When the effects of the three most important factors were accounted for in graded tumors, then none of the following were prognostic: histologic type, dense adhesion, extracapsular growth, ascites, rupture during surgery, International Federation of Gynecology and Obstetrics (1 973) stage, size of tumor, and age and type of adjuvant treatment. None of 77 patients with well differentiated deoxyribonucleic acid diploid tumors had relapses. CONCLUSION: Deoxyribonucleic acid ploidy is an important new independent prognostic factor in stage I ovarian carcinoma.
引用
收藏
页码:40 / 52
页数:13
相关论文
共 31 条
[1]  
BAAK JPA, 1987, ANAL QUANT CYTOL, V9, P287
[2]  
BARNABEI VM, 1990, AM J OBSTET GYNECOL, V162, P1584
[3]  
BRESCIA RJ, 1990, CANCER, V65, P141, DOI 10.1002/1097-0142(19900101)65:1<141::AID-CNCR2820650128>3.0.CO
[4]  
2-I
[5]  
DEMBO AJ, 1990, OBSTET GYNECOL, V75, P263
[6]   FLOW CYTOMETRIC ANALYSIS OF DNA CONTENT IN HUMAN OVARIAN CANCERS [J].
ERBA, E ;
UBEZIO, P ;
PEPE, S ;
VAGHI, M ;
MARSONI, S ;
TORRI, W ;
MANGIONI, C ;
LANDONI, F ;
DINCALCI, M .
BRITISH JOURNAL OF CANCER, 1989, 60 (01) :45-50
[7]   IS STAGE-I EPITHELIAL OVARIAN-CANCER OVERTREATED BOTH SURGICALLY AND SYSTEMICALLY - RESULTS OF A 5-YEAR CANCER REGISTRY REVIEW [J].
FINN, CB ;
LUESLEY, DM ;
BUXTON, EJ ;
BLACKLEDGE, GR ;
KELLY, K ;
DUNN, JA ;
WILSON, S .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1992, 99 (01) :54-58
[8]   DNA FLOW-CYTOMETRY OF CELLS OBTAINED FROM OLD PARAFFIN-EMBEDDED SPECIMENS - A COMPARISON WITH RESULTS OF SCANNING ABSORPTION CYTOMETRY (A METHODOLOGICAL STUDY) [J].
FOSSA, SD ;
THORUD, E ;
SHOAIB, MC ;
PETTERSEN, EO .
PATHOLOGY RESEARCH AND PRACTICE, 1986, 181 (02) :200-205
[9]   PLOIDY AS A PROGNOSTIC FACTOR IN OVARIAN-CANCER [J].
FRIEDLANDER, ML ;
TAYLOR, IW ;
RUSSELL, P ;
MUSGROVE, EA ;
HEDLEY, DH ;
TATTERSALL, MHN .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1983, 2 (01) :55-63
[10]  
HAAPASALO H, 1991, ANAL CELL PATHOL, V3, P261